Price
Financials
Consolidated, Rs crore| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 22 | 27 | 43 | 56 | 67 | 65 |
| Expenses | 15 | 16 | 28 | 34 | 35 | 43 |
| Operating Profit | 7 | 10 | 15 | 21 | 32 | 22 |
| OPM % | 32% | 39% | 35% | 38% | 48% | 34% |
| Other Income | 1 | 1 | 2 | 1 | 3 | 2 |
| Interest | 2 | 2 | 2 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 2 | 4 | 4 | 6 |
| Profit before tax | 5 | 8 | 13 | 18 | 30 | 17 |
| Tax % | 17% | 28% | 29% | -2% | 4% | -2% |
| Net Profit | 4 | 6 | 9 | 18 | 29 | 17 |
| EPS in Rs | 9.75 | 6.83 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 22 | 26 | 37 | 44 | 49 | 99 | 132 |
| Expenses | 20 | 20 | 25 | 30 | 31 | 62 | 78 |
| Operating Profit | 2 | 7 | 12 | 14 | 18 | 37 | 54 |
| OPM % | 10% | 25% | 31% | 31% | 36% | 37% | 41% |
| Other Income | 1 | 2 | 1 | 2 | 2 | 3 | 5 |
| Interest | 2 | 1 | 5 | 4 | 3 | 3 | 2 |
| Depreciation | 2 | 2 | 2 | 3 | 2 | 6 | 10 |
| Profit before tax | -1 | 5 | 5 | 9 | 14 | 30 | 46 |
| Tax % | 2% | 9% | 27% | 17% | 24% | 11% | 2% |
| Net Profit | -1 | 5 | 4 | 8 | 10 | 27 | 46 |
| EPS in Rs | 16.45 | ||||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 38% | 44% | 33% | ||
| Compounded Profit Growth | % | 39% | 49% | 81% | ||
| Stock Price CAGR | % | % | 70% | 282% | ||
| Return on Equity | % | 20% | 19% | 21% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 1 | 15 | 15 | 16 |
| Reserves | 4 | 9 | 13 | 26 | 70 | 86 | 122 |
| Borrowings | 41 | 39 | 38 | 39 | 15 | 22 | 33 |
| Other Liabilities | 12 | 9 | 12 | 12 | 10 | 62 | 84 |
| Total Liabilities | 58 | 58 | 65 | 78 | 110 | 185 | 254 |
| Fixed Assets | 35 | 35 | 36 | 37 | 36 | 68 | 84 |
| CWIP | 2 | 0 | 0 | 0 | 0 | 5 | 10 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 20 | 22 | 28 | 41 | 74 | 112 | 160 |
| Total Assets | 58 | 58 | 65 | 78 | 110 | 185 | 254 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 1 | 4 | 9 | 1 | 5 | 3 | 6 |
| Cash from Investing Activity | -1 | 0 | -4 | -5 | 0 | -5 | -19 |
| Cash from Financing Activity | 1 | -3 | -5 | 3 | 22 | -3 | 16 |
| Net Cash Flow | 0 | 1 | 0 | -0 | 27 | -5 | 2 |
| Free Cash Flow | -1 | 4 | 8 | -1 | 2 | -13 | -26 |
| CFO/OP | 32% | 62% | 82% | 22% | 40% | 18% | 16% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 206 | 198 | 180 | 228 | 251 | 303 | 341 |
| Inventory Days | 50 | 86 | 78 | 98 | 88 | 74 | 100 |
| Days Payable | 382 | 91 | 79 | 137 | 104 | 104 | 138 |
| Cash Conversion Cycle | -125 | 192 | 180 | 188 | 235 | 273 | 304 |
| Working Capital Days | 24 | 137 | 87 | 141 | 203 | 239 | 321 |
| ROCE % | 14% | 20% | 22% | 20% | 25% | 24% |
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|
| Promoters | 68.80% | 68.80% | 68.93% | 68.93% | 69.14% | 69.53% | 64.82% |
| FIIs | 5.61% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% |
| DIIs | 3.31% | 0.14% | 0.02% | 0.23% | 0.75% | 0.48% | 0.45% |
| Public | 22.27% | 31.05% | 31.05% | 30.83% | 30.11% | 29.99% | 34.73% |
| No. of Shareholders | 1,111 | 979 | 984 | 985 | 1,058 | 1,162 | 1,210 |
Fundamentals
Market Cap₹ 996 Cr.
Current Price₹ 626
Stock P/E38.8
Book Value₹ 87.6
ROCE24.5 %
ROE21.5 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)33%
Compounded Profit Growth (TTM)81%
Consolidated figures.
Valuation
Market capRs 924 Cr
Enterprise valueRs 961 Cr
P/E (TTM)120.33x
Price to book33.58x
Price to sales21.04x
EV / EBITDA61.12x
EV / EBIT72.78x
EV / sales21.89x
Price to cash flow694.82x
Earnings yield0.83%
Profitability
Operating margin (excl. other income)31.03%
Operating margin (incl. other income)35.81%
EBITDA margin35.81%
Pre-tax margin21.10%
Net profit margin17.48%
ROE36.30%
ROCE22.09%
ROA10.73%
ROE, 3-year average42.48%
ROCE, 3-year average18.86%
ROA, 3-year average8.51%
ROIC (approx.)16.81%
Tax rate17.48%
Other income / net worth7.63%
Growth
Sales growth (latest year)19.28%
Profit growth (latest year)101.05%
Sales CAGR, 3 years25.49%
Per share
EPS (TTM)Rs 4.83
EPS (latest year)Rs 55.27
EPS, 3-year averageRs 40.36
Book value per shareRs 17.31
Sales per shareRs 27.63
Cash flow per shareRs 0.84
Free cash flow per shareRs -16.35
Efficiency
Asset turnover0.56x
Fixed asset turnover1.18x
Inventory turnover4.46x
Inventory days82 days
Debtor days228 days
Debtors turnover1.60x
Creditor days138 days
Cash conversion cycle304 days
Working capital days321 days
Leverage
Total debtRs 39 Cr
Cash and bankRs 2 Cr
Net debtRs 37 Cr
Debt to equity1.43x
Net debt / EBITDA2.37x
Interest coverage3.35x
Owners' fund to total sources35.13%
Debt to assets50.13%
Cash flow
Cash from Operating Activity (latest year)Rs 1 Cr
Cash from Investing Activity (latest year)Rs -5 Cr
Cash from Financing Activity (latest year)Rs 3 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs -26 Cr
FCFE (approx.: FCF + change in debt)Rs -25 Cr
Cash from ops / profit, 5 years0.25x
Sales to cash flow33.03x
Statement figures
Net sales (TTM)Rs 44 Cr
Net sales (latest year)Rs 44 Cr
Operating profit excl. other income (latest year)Rs 14 Cr
Other income (TTM)Rs 2 Cr
EBITDA (TTM)Rs 16 Cr
PBDT (TTM)Rs 12 Cr
Profit before tax (TTM)Rs 9 Cr
Tax (latest year)Rs 2 Cr
Net profit (TTM)Rs 8 Cr
Net profit (latest year)Rs 8 Cr
Depreciation (TTM)Rs 3 Cr
Interest (TTM)Rs 4 Cr
Cost of goods sold (latest year)Rs 9 Cr
Total expenditure (latest year)Rs 30 Cr
Total income (latest year)Rs 46 Cr
Share capitalRs 1 Cr
ReservesRs 26 Cr
Shareholders' fundsRs 28 Cr
Total assetsRs 78 Cr
Net blockRs 37 Cr
InvestmentsRs 0 Cr
ReceivablesRs 27 Cr
InventoryRs 2 Cr
Other liabilitiesRs 12 Cr
Shares outstanding (crore)1.59
Ownership
Promoter holding64.82% (-4.11 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 120.3 is at the 62th percentile of its own 2.4-year range
(median 69.9, low 37.9, high 200.0).
P/B 33.58 is at the 50th percentile (median 32.15).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | UNIHEALTH | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -11.4% | -2.8% | -8.6 pts |
| 1 month | -19.3% | -6.8% | -12.5 pts |
| 3 months | -7.0% | -7.6% | +0.7 pts |
| 6 months | +60.4% | +0.4% | +60.0 pts |
| 1 year | +248.5% | -9.9% | +258.5 pts |
| 2 years | +267.5% | -13.6% | +281.1 pts |
| 3 years | +353.4% | +14.2% | +339.2 pts |
Red flags
F-score 4 of 8| explain | Receivables outrunning sales Receivables grew 51% vs sales +19% in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹65 Cr +140.7% vs Mar 2024.
Net profit ₹17 Cr +183.3%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Close to Close price movement greater than 100perc in previous 365 daysClose to Close price movement greater than 200perc in previous 365 DaysHigh low price variation greater than 300perc in previous 365 DaysLess than 100 unique PAN traded in previous 30 daysMandatory Market making period in SME scrip is overSME scrip is not regularly traded
Quick answers
What is the market cap of Unihealth Hospitals Ltd?
Unihealth Hospitals Ltd (UNIHEALTH) has a market capitalisation of Rs 996 Cr. at the 2026-10-01 close.
What is the P/E ratio of Unihealth Hospitals Ltd?
Unihealth Hospitals Ltd trades at a P/E of 38.8 on trailing twelve-month profit, at the 2026-10-01 close.
What were Unihealth Hospitals Ltd's latest quarterly results?
In the Mar 2026 quarter, Unihealth Hospitals Ltd sales was Rs 65 Cr (+140.7% vs Mar 2024) and net profit was Rs 17 Cr.
What is the 52-week high and low of Unihealth Hospitals Ltd?
The 52-week high is Rs 820.00 and the 52-week low is Rs 153.55.